Profiles on Therapy Area

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Achillion Pharmaceuticals, Inc.

Achillion Pharmaceuticals (Achillion or 'the company') is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of infectious diseases such as chronic hepatitis C virus (HCV) and resistant bacterial infections. The company operates in the US where it is headquartered in New Haven, Connecticut. Achillion had 56 full-time employees and one part-time employee as of February 11, 2013.

Published By MarketLine
06 Nov 2013 $175
Buy
Company Profile
Company Profile

Acorda Therapeutics, Inc.

Acorda Therapeutics (Acorda or 'the company') is a commercial-stage biotechnology company engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. Acorda's marketed products include Ampyra/Fampyra (dalfampridine) and Zanaflex capsules and tablets (tizanidine hydrochloride). The company primarily operates in the US, where it is headquartered in Ardsley, New York, and employed 378

Published By MarketLine
20 Sep 2013 $175
Buy
Company Profile
Company Profile

Actavis, Inc.

Actavis (or 'the company'), formerly known as Watson Pharmaceuticals, is an integrated global specialty pharmaceutical company focused on the development, manufacture, marketing, sale and distribution of generic, branded and biosimilar products. In January 2013, Watson Pharmaceuticals changed its name to Actavis, Inc. The company operates in the Americas, Europe and Asia. Actavis is headquartered in Parsippany, New Jersey, and employed 17,700 people as of December 31, 2012.

Published By MarketLine
27 Aug 2013 $175
Buy
Company Profile
Company Profile

Actelion Ltd

Actelion (or 'the company') is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic small-molecule drugs to address high unmet medical needs. It has affiliates in more than 30 countries including the US, Canada, Brazil, Australia, Japan and Switzerland, which provide distribution, sales and marketing services. Actelion has operations in the Americas, Europe and Asia-Pacific. The company is headquartered in Allschwil, Switzerland and employed 2,433 people as

Published By MarketLine
28 Oct 2013 $175
Buy
Company Profile
Company Profile

Alcon

Alcon (or 'the company'), a Novartis company, is engaged in the development, manufacture and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products for the treatment of eye disorders. The company markets its products across 180 countries and operates in over 75 countries. It primarily operates in the US, Japan and Switzerland. Alcon is headquartered in Texas, the US, and employed 25,494 people as of December 31, 2013.

Published By MarketLine
29 Apr 2014 $175
Buy
Company Profile
Company Profile

ALK-Abello AS

ALK-Abello (or 'the group') is a Denmark-based pharmaceutical group engaged in the development and marketing of allergy treatment products. The group operates in Europe, the US, Canada, China and other parts of the world. It is headquartered in Horsholm, Denmark, and employed 1,855 people as on December 31, 2012.

Published By MarketLine
10 Dec 2013 $175
Buy
Company Profile
Company Profile

Allergan, Inc.

Allergan (or 'the company') is engaged in the discovery, development and commercialization of products addressing ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention and other specialty markets. The company primarily operates in the US, Europe, Asia Pacific and Latin America. The company is headquartered in Irvine, California, and employed approximately 10,800 people as of December 31, 2012.

Published By MarketLine
04 Oct 2013 $175
Buy
Company Profile
Company Profile

Almirall S.A.

Almirall (or 'the group') is principally engaged in the research, development, storage, and commercialization of proprietary drugs as well as licensed products. Its products are sold in over 70 countries, with a direct presence in Europe and Latin America. Almirall is headquartered in Barcelona, Spain, and employed about 3,000 people at the end of December 2013.

Published By MarketLine
20 Jun 2014 $175
Buy
Company Profile
Company Profile

Amgen, Inc.

Amgen (or 'the company') is a leading biotechnology company engaged in the discovery, development, manufacture, and marketing of innovative human therapeutics. The company mainly focuses in the areas of cancer, kidney disease, rheumatoid arthritis and other serious illnesses. It primarily operates in the US where it is headquartered in Thousand Oaks, California. Amgen employed about 20,000 people as of December 31, 2013.

Published By MarketLine
27 Jun 2014 $175
Buy
Company Profile
Company Profile

Amylin Pharmaceuticals, LLC

Amylin Pharmaceuticals, LLC (Amylin or 'the company'), a wholly-owned subsidiary of Bristol-Myers Squibb (BMS), is a biopharmaceutical company engaged in the development of potential therapies to treat diabetes and obesity. Amylin currently markets Byetta, Symlin and Bydureon for the treatment of diabetes. The company primarily operates in the US, where it is headquartered in San Diego, California. It employed about 1,300 people as of December 31, 2011.

Published By MarketLine
08 Jan 2013 $175
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.